Status:
COMPLETED
Serum Progesterone on the Day of Embryo Transfer and Pregnancy Rate.
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Ongoing Pregnancy Rate
Eligibility:
FEMALE
18-50 years
Brief Summary
This study aims to analyze whether serum Progsterone levels on the day of Embryo Transfer are related with Ongoing Pregnancy rate in artificial endometrial preparation cycles with intravaginal microni...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age \<50 years old
- Hormonal Replacement therapy cycle for embryo transfer in any of the following situations:
- Embryos in fresh cycle with donated oocytes.
- Subsequent embryo transfers of vitrified embryos in cycles of donated oocytes.
- Frozen embryo transfers in cycles with autologous oocytes.
- Endometrial line: \>6.5-7mm (with trilaminar aspect) in proliferative phase, before introducing progesterone.
- Administration of natural micronized progesterone intravaginally (400 mg/12 hours for 5 complete days (10 dosis), before the embryo transfer and maintained until pregnancy week 12.
- Embryo transfer of blastocyst (day 5-6).
- Signed Informed Consent
- Exclusion Criteria
- Uterine pathology (submucous o intramural fibroids (\>4 cm) or which deform the uterine cavity; endometrial polyps or Müllerian anomalies; or adnexal anomalies (communicating hydrosalpinx).
- Simultaneous participation in another clinical study.
- Participation in another clinical study before the inclusion in the present study, and which could affect the objectives of the present study.
Exclusion
Key Trial Info
Start Date :
September 8 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 28 2018
Estimated Enrollment :
1205 Patients enrolled
Trial Details
Trial ID
NCT03272412
Start Date
September 8 2017
End Date
November 28 2018
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Valenciano de Infertilidad Spain
Valencia, Spain, 46015